Drug resistance in children and adolescents with HIV in Panama
Journal of Antimicrobial Chemotherapy · 2023
DOI: 10.1093/jac/dkac407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Judit Ventosa-Cubillo und 5 weiteren Autor:innen. Beteiligte Einrichtung: HIV-1 Molecular Epidemiology Laboratory, Microbiology and Parasitology Department, Hospital Ramón y Cajal-IRYCIS and CIBERESP-ISCIII-RITIP-CoRISpe-PL…. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CYTED, Spanish HIV infected Paediatric Cohort, CoRISpe.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objectives
The inadequacy of resistance monitoring in Latin America leads to circulation of HIV strains with drug resistance mutations (DRMs), compromising ART effectiveness. This study describes the DRM prevalence in HIV-infected paediatric patients in Panama.
Methods
During 2018–19, plasma was collected from 76 HIV-infected children/adolescents (5 ART-naive, 71 treated) in Panama for HIV-1 DRM pol analysis, predicted antiretroviral (ARV) susceptibility by Stanford, and HIV-1 variant phylogenetic characterization.
Results
HIV-1 pol sequences were recovered from 67 (88.2%) of 76 children/adolescents (median age 12 years), carrying 65 subtype B, 1 subtype G and 1 unique recombinant URF_A1B. Five were ART-naive and 62 ART-treated under virological failure (viraemia >50 copies/mL) with previous exposure to NRTIs, (100%), NNRTIs (45.2%), PIs (95.2%) and integrase strand transfer inhibitors (INSTIs, 17.7%). Among the treated patients, 34 (54.8%) carried resistant strains, with major DRMs to one (40.3%), two (9.7%) or three (4.8%) ARV families. Most of them harboured DRMs to NRTIs (58.5%) or NNRTIs (39%), but also major DRMs to PIs (4.9%) and INSTIs (6.5%). We also found dual-class NRTI + NNRTI (12.2%) and NNRTI + PI (2.6%) resistance. Two naive subjects carried viruses with DRMs to NRTIs and NRTI + NNRTI, respectively. Sequenced viruses presented high/intermediate resistance mainly to emtricitabine/lamivudine (48.9% each) and efavirenz/nevirapine (33.3% each). Most participants were susceptible to PIs (91.3%) and INSTIs (88.1%).
Conclusions
The high DRM prevalence to NRTIs and NNRTIs observed among treated HIV-infected children/adolescents in Panama justifies the need for routine resistance monitoring for optimal rescue therapy selection in this vulnerable population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- HIV-1 Molecular Epidemiology Laboratory, Microbiology and Parasitology Department, Hospital Ramón y Cajal-IRYCIS and CIBERESP-ISCIII-RITIP-CoRISpe-PLANTAIDS-CYTED, Madrid, Spain.
- Hospital del Niño Doctor José Renán Esquivel, PLANTAIDS-CYTED, Panamá.
- Microbiology Department. Hospital Universitario Central de Asturias (HUCA) and Grupo de Investigación Microbiología Traslacional, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
- Sistema Nacional de Investigación, Secretaría Nacional de Ciencia, tecnología e Innovación, Panamá.
- Hospital Gregorio Marañón, IISGM, UCM, PLANTAIDS programa CYTED-CIBERINFEC-ISCIII, Madrid, Spain.
Förderung
- CYTED
- Spanish HIV infected Paediatric Cohort
- CoRISpe
Zitieren
APA
Ventosa-Cubillo, J., Pinzón, R., González-Alba, J. M., Estripeaut, D., Navarro, M. L., & Holguín, Á. (2023). Drug resistance in children and adolescents with HIV in Panama. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkac407
Vancouver
Ventosa-Cubillo J, Pinzón R, González-Alba JM, Estripeaut D, Navarro ML, Holguín Á. Drug resistance in children and adolescents with HIV in Panama. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkac407
BibTeX
@article{VentosaCubillo2023,
author = {Ventosa-Cubillo, Judit and Pinzón, Ramón and González-Alba, José María and Estripeaut, Dora and Navarro, María Luisa and Holguín, África},
title = {Drug resistance in children and adolescents with HIV in Panama},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2023},
doi = {10.1093/jac/dkac407}
}
EUVIMED